Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

648 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic Impact of Chronic Vasodilator Therapy in Patients With Vasospastic Angina.
Lim Y, Kim MC, Ahn Y, Cho KH, Sim DS, Hong YJ, Kim JH, Jeong MH, Baek SH, Her SH, Lee KY, Han SH, Rha SW, Choi DJ, Gwon HC, Kwon HM, Yang TH, Park KH, Jo SH. Lim Y, et al. Among authors: kwon hm. J Am Heart Assoc. 2022 Apr 5;11(7):e023776. doi: 10.1161/JAHA.121.023776. Epub 2022 Mar 29. J Am Heart Assoc. 2022. PMID: 35347998 Free PMC article.
Everolimus-eluting versus sirolimus-eluting stents in patients undergoing percutaneous coronary intervention: the EXCELLENT (Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting) randomized trial.
Park KW, Chae IH, Lim DS, Han KR, Yang HM, Lee HY, Kang HJ, Koo BK, Ahn T, Yoon JH, Jeong MH, Hong TJ, Chung WY, Jo SH, Choi YJ, Hur SH, Kwon HM, Jeon DW, Kim BO, Park SH, Lee NH, Jeon HK, Gwon HC, Jang YS, Kim HS. Park KW, et al. Among authors: kwon hm. J Am Coll Cardiol. 2011 Oct 25;58(18):1844-54. doi: 10.1016/j.jacc.2011.07.031. J Am Coll Cardiol. 2011. PMID: 22018294 Free article. Clinical Trial.
Six-month versus 12-month dual antiplatelet therapy after implantation of drug-eluting stents: the Efficacy of Xience/Promus Versus Cypher to Reduce Late Loss After Stenting (EXCELLENT) randomized, multicenter study.
Gwon HC, Hahn JY, Park KW, Song YB, Chae IH, Lim DS, Han KR, Choi JH, Choi SH, Kang HJ, Koo BK, Ahn T, Yoon JH, Jeong MH, Hong TJ, Chung WY, Choi YJ, Hur SH, Kwon HM, Jeon DW, Kim BO, Park SH, Lee NH, Jeon HK, Jang Y, Kim HS. Gwon HC, et al. Among authors: kwon hm. Circulation. 2012 Jan 24;125(3):505-13. doi: 10.1161/CIRCULATIONAHA.111.059022. Epub 2011 Dec 16. Circulation. 2012. PMID: 22179532 Clinical Trial.
Trial of everolimus-eluting stents or bypass surgery for coronary disease.
Park SJ, Ahn JM, Kim YH, Park DW, Yun SC, Lee JY, Kang SJ, Lee SW, Lee CW, Park SW, Choo SJ, Chung CH, Lee JW, Cohen DJ, Yeung AC, Hur SH, Seung KB, Ahn TH, Kwon HM, Lim DS, Rha SW, Jeong MH, Lee BK, Tresukosol D, Fu GS, Ong TK; BEST Trial Investigators. Park SJ, et al. Among authors: kwon hm. N Engl J Med. 2015 Mar 26;372(13):1204-12. doi: 10.1056/NEJMoa1415447. Epub 2015 Mar 16. N Engl J Med. 2015. PMID: 25774645 Free article. Clinical Trial.
Predictors and Long-Term Clinical Outcome of Longitudinal Stent Deformation: Insights From Pooled Analysis of Korean Multicenter Drug-Eluting Stent Cohort.
Rhee TM, Park KW, Lee JM, Lee MS, Jeon KH, Kang HJ, Koo BK, Rhew JY, Cha KS, Bae JH, Han KR, Park SH, Park WJ, Rha SW, Oh SK, Kwon HM, Seung KB, Ahn T, Kim SH, Kim HS. Rhee TM, et al. Among authors: kwon hm. Circ Cardiovasc Interv. 2017 Nov;10(11):e005518. doi: 10.1161/CIRCINTERVENTIONS.117.005518. Circ Cardiovasc Interv. 2017. PMID: 29146671
Comparison of efficacy and safety between two different irbesartan, generic vs branded, in the treatment of Korean patients with mild-to-moderate hypertension: an 8-week, multicenter, randomized, open-label, Phase IV clinical study.
Han SH, Oh GC, Kwon HM, Park CG, Kim IJ, Hwang GS, Yoo BS, Park SH, Lee KJ, Kim HS. Han SH, et al. Among authors: kwon hm. Drug Des Devel Ther. 2018 Dec 19;12:4217-4229. doi: 10.2147/DDDT.S172046. eCollection 2018. Drug Des Devel Ther. 2018. PMID: 30587918 Free PMC article. Clinical Trial.
648 results